|
1
|
Kerr JS, Adriaanse BA, Greig NH, Mattson
MP, Cader MZ, Bohr VA and Fang EF: Mitophagy and Alzheimer's
disease: Cellular and molecular mechanisms. Trends Neurosci.
40:151–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stephenson-Jones M, Yu K, Ahrens S,
Tucciarone JM, van Huijstee AN, Mejia LA, Penzo MA, Tai LH,
Wilbrecht L and Li B: A basal ganglia circuit for evaluating action
outcomes. Nature. 539:289–293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pereira JB, Janelidze S, Ossenkoppele R,
Kvartsberg H, Brinkmalm A, Mattsson-Carlgren N, Stomrud E, Smith R,
Zetterberg H, Blennow K, et al: Untangling the association of
amyloid-β and tau with synaptic and axonal loss in Alzheimer's
disease. Brain awaa395. 2020. View Article : Google Scholar
|
|
4
|
Hardy J and Selkoe DJ: The amyloid
hypothesis of Alzheimer's disease: progress and problems on the
road to therapeutics. Science. 297:353–356. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin Y-T, Seo J, Gao F, Feldman HM, Wen HL,
Penney J, Cam HP, Gjoneska E, Raja WK, Cheng J, et al: APOE4 causes
widespread molecular and cellular alterations associated with
Alzheimer's disease phenotypes in human iPSC-derived brain cell
types. Neuron. 98:1141–1154.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang EF, Hou Y, Palikaras K, Adriaanse BA,
Kerr JS, Yang B, Lautrup S, Hasan-Olive MM, Caponio D, Dan X, et
al: Mitophagy inhibits amyloid-β and tau pathology and reverses
cognitive deficits in models of Alzheimer's disease. Nat Neurosci.
22:401–412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lautrup S, Sinclair DA, Mattson MP and
Fang EF: NAD+ in brain aging and neurodegenerative
disorders. Cell Metab. 30:630–655. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang P, Kishimoto Y, Grammatikakis I,
Gottimukkala K, Cutler RG, Zhang S, Abdelmohsen K, Bohr VA, Misra
Sen J, Gorospe M, et al: Senolytic therapy alleviates Aβ-associated
oligodendrocyte progenitor cell senescence and cognitive deficits
in an Alzheimer's disease model. Nat Neurosci. 22:719–728. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oertle T, van der Haar ME, Bandtlow CE,
Robeva A, Burfeind P, Buss A, Huber AB, Simonen M, Schnell L,
Brösamle C, et al: Nogo-A inhibits neurite outgrowth and cell
spreading with three discrete regions. J Neurosci. 23:5393–5406.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huebner EA and Strittmatter SM: Axon
regeneration in the peripheral and central nervous systems. Results
Probl Cell Differ. 48:339–351. 2009.PubMed/NCBI
|
|
11
|
Grandpré T and Strittmatter SM: Nogo: A
molecular determinant of axonal growth and regeneration.
Neuroscientist. 7:377–386. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mosyak L, Wood A, Dwyer B, Buddha M,
Johnson M, Aulabaugh A, Zhong X, Presman E, Benard S, Kelleher K,
et al: The structure of the Lingo-1 ectodomain, a module implicated
in central nervous system repair inhibition. J Biol Chem.
281:36378–36390. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gil V, Nicolas O, Mingorance A, Ureña JM,
Tang BL, Hirata T, Sáez-Valero J, Ferrer I, Soriano E and del Río
JA: Nogo-A expression in the human hippocampus in normal aging and
in Alzheimer disease. J Neuropathol Exp Neurol. 65:433–444. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang Y, Yao L, Li C, Wang J, Wang J, Chen
S, Zhou XF and Liao H: The blockage of the Nogo/NgR signal pathway
in microglia alleviates the formation of Aβ plaques and tau
phosphorylation in APP/PS1 transgenic mice. J Neuroinflammation.
13:562016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiao F, Lin LF, Cheng X, Gao Q and Luo HM:
Nogo-66 receptor activation inhibits neurite outgrowth and
increases β-amyloid protein secretion of cortical neurons. Mol Med
Rep. 5:619–624. 2012.PubMed/NCBI
|
|
16
|
Dai X, Sun Z, Liang R, Li Y, Luo H, Huang
Y, Chen M, Su Z and Xiao F: Recombinant Nogo-66 via soluble
expression with SUMO fusion in Escherichia coli inhibits neurite
outgrowth in vitro. Appl Microbiol Biotechnol. 99:5997–6007. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
zur Nedden S, Doney AS and Frenguelli BG:
Modulation of intracellular ATP determines adenosine release and
functional outcome in response to metabolic stress in rat
hippocampal slices and cerebellar granule cells. J Neurochem.
128:111–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao R, Wang Y, Pan Q, Huang G, Li N, Mou J
and Wang D: Fuzhisan, a chinese herbal medicine, suppresses
beta-secretase gene transcription via upregulation of SIRT1
expression in N2a-APP695 cells. Int J Clin Exp Med. 8:7231–7240.
2015.PubMed/NCBI
|
|
19
|
Jin SG, Ryu HH, Li SY, Li CH, Lim SH, Jang
WY and Jung S: Nogo-A inhibits the migration and invasion of human
malignant glioma U87MG cells. Oncol Rep. 35:3395–3402. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan J, Zhou X, Guo JJ, Mao L, Wang YJ, Sun
J, Sun LX, Zhang LY, Zhou XF and Liao H: Nogo-66 inhibits adhesion
and migration of microglia via GTPase Rho pathway in vitro. J
Neurochem. 120:721–731. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
GrandPré T, Nakamura F, Vartanian T and
Strittmatter SM: Identification of the Nogo inhibitor of axon
regeneration as a Reticulon protein. Nature. 403:439–444. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen MS, Huber AB, van der Haar ME, Frank
M, Schnell L, Spillmann AA, Christ F and Schwab ME: Nogo-A is a
myelin-associated neurite outgrowth inhibitor and an antigen for
monoclonal antibody IN-1. Nature. 403:434–439. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niederöst B, Oertle T, Fritsche J,
McKinney RA and Bandtlow CE: Nogo-A and myelin-associated
glycoprotein mediate neurite growth inhibition by antagonistic
regulation of RhoA and Rac1. J Neurosci. 22:10368–10376. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou X, Hu X, He W, Tang X, Shi Q, Zhang Z
and Yan R: Interaction between amyloid precursor protein and Nogo
receptors regulates amyloid deposition. FASEB J. 25:3146–3156.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park JH, Gimbel DA, GrandPre T, Lee JK,
Kim JE, Li W, Lee DH and Strittmatter SM: Alzheimer precursor
protein interaction with the Nogo-66 receptor reduces amyloid-beta
plaque deposition. J Neurosci. 26:1386–1395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang R, Wu XF, Wang B, Guan RX, Lv LM, Li
AP, Lei L, Ma Y, Li N, Li QF, et al: Reduction of NgR in perforant
path decreases amyloid-β peptide production and ameliorates
synaptic and cognitive deficits in APP/PS1 mice. Alzheimers Res
Ther. 12:472020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He W, Lu Y, Qahwash I, Hu X-Y, Chang A and
Yan R: Reticulon family members modulate BACE1 activity and
amyloid-β peptide generation. Nat Med. 10:959–965. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murayama KS, Kametani F, Saito S, Kume H,
Akiyama H and Araki W: Reticulons RTN3 and RTN4-B/C interact with
BACE1 and inhibit its ability to produce amyloid β-protein. Eur J
Neurosci. 24:1237–1244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Masliah E, Xie F, Dayan S, Rockenstein E,
Mante M, Adame A, Patrick CM, Chan AF and Zheng B: Genetic deletion
of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes
in amyloid precursor protein transgenic mice. Neuroscience.
169:488–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu W, Xiao P, Fan S, Chen Y, Huang W, Chen
X, Liu G, Dang C, Zeng J and Xing S: Blockade of Nogo-A/Nogo-66
receptor 1 (NgR1) inhibits autophagic activation and prevents
secondary neuronal damage in the thalamus after focal cerebral
infarction in hypertensive rats. Neuroscience. 431:103–114. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X,
Gonzalez-DeWhitt PA, Gelfanova V, Hale JE, May PC, et al:
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic
Abeta42 by inhibiting Rho. Science. 302:1215–1217. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Herskowitz JH, Feng Y, Mattheyses AL,
Hales CM, Higginbotham LA, Duong DM, Montine TJ, Troncoso JC,
Thambisetty M, Seyfried NT, et al: Pharmacologic inhibition of
ROCK2 suppresses amyloid-β production in an Alzheimer's disease
mouse model. J Neurosci. 33:19086–19098. 2013. View Article : Google Scholar : PubMed/NCBI
|
